SCHEMBL2728236

SCHEMBL2728236

COc1ccc(-c2c3cc(F)ccc3c(-c3ccc(F)cc3F)c3c(F)c(F)c(F)c(F)c23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MAOB P27338 1/20 0.39
HPGD P15428 1/20 0.39
LMNA P02545 2/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
APP P05067 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPK13 O15264 1/20 0.36
MAPK12 P53778 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
AMY1A P0DUB6 1/20 0.36
SYK P43405 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12086217 1.00 ALDH1A1 (0.39) ALDH1A1MEN1KMT2AKDM4EMAOB
SCHEMBL2725004 0.92 SYK (0.40) ALDH1A1MEN1KMT2AKDM4EMAOB
SCHEMBL12086222 0.91 ALDH1A1 (0.40) ALDH1A1MEN1KMT2AKDM4EMAOB
SCHEMBL2727342 0.91 ALDH1A1 (0.40) ALDH1A1MEN1KMT2AKDM4EMAOB
SCHEMBL2710033 0.88 APP (0.40) ALDH1A1MEN1KMT2AKDM4EMAOB
SCHEMBL2727061 0.87 MEN1 (0.46) ALDH1A1MEN1KMT2AKDM4EMAOB
SCHEMBL2724966 0.87 MEN1 (0.42) ALDH1A1MEN1KMT2AKDM4EMAOB
SCHEMBL2710179 0.86 AMY1A (0.36) MAPK14AMY1ANFE2L2NPC1RAB9A
SCHEMBL12086155 0.86 AMY1A (0.36) MAPK14AMY1ANFE2L2NPC1RAB9A
SCHEMBL2712297 0.86 MEN1 (0.42) ALDH1A1MEN1KMT2AKDM4EMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 ALDH1A1 34/4885MEN1 1898/4885KMT2A 3905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.